6389 related articles for article (PubMed ID: 10761789)
1. Can elective lymph node dissection decrease the frequency and mortality rate of late melanoma recurrences?
Shen P; Guenther JM; Wanek LA; Morton DL
Ann Surg Oncol; 2000 Mar; 7(2):114-9. PubMed ID: 10761789
[TBL] [Abstract][Full Text] [Related]
2. Patterns of initial recurrence and prognosis after sentinel lymph node biopsy and selective lymphadenectomy for melanoma.
Wagner JD; Ranieri J; Evdokimow DZ; Logan T; Chuang TY; Johnson CS; Jung SH; Wenck S; Coleman JJ
Plast Reconstr Surg; 2003 Aug; 112(2):486-97. PubMed ID: 12900606
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of lymphatic mapping, sentinel lymphadenectomy, and selective complete lymph node dissection as a therapeutic procedure for early-stage melanoma.
Essner R; Conforti A; Kelley MC; Wanek L; Stern S; Glass E; Morton DL
Ann Surg Oncol; 1999; 6(5):442-9. PubMed ID: 10458681
[TBL] [Abstract][Full Text] [Related]
4. Risk factors for nodal recurrence after lymphadenectomy for melanoma.
Pidhorecky I; Lee RJ; Proulx G; Kollmorgen DR; Jia C; Driscoll DL; Kraybill WG; Gibbs JF
Ann Surg Oncol; 2001 Mar; 8(2):109-15. PubMed ID: 11258774
[TBL] [Abstract][Full Text] [Related]
5. Elective, therapeutic, and delayed lymph node dissection for malignant melanoma of the head and neck: analysis of 1444 patients from 1970 to 1998.
Fisher SR
Laryngoscope; 2002 Jan; 112(1):99-110. PubMed ID: 11802046
[TBL] [Abstract][Full Text] [Related]
6. The role of elective lymph node dissection in the management of patients with thick cutaneous melanoma.
Crowley NJ; Seigler HF
Cancer; 1990 Dec; 66(12):2522-7. PubMed ID: 2249194
[TBL] [Abstract][Full Text] [Related]
7. Sentinel node biopsy provides more accurate staging than elective lymph node dissection in patients with cutaneous melanoma.
Doubrovsky A; De Wilt JH; Scolyer RA; McCarthy WH; Thompson JF
Ann Surg Oncol; 2004 Sep; 11(9):829-36. PubMed ID: 15313732
[TBL] [Abstract][Full Text] [Related]
8. [Elective lymph node dissection in primary malignant melanoma].
Petres J; Rompel R; Büttner P; Teichelmann K; Garbe C
Hautarzt; 1996 Jan; 47(1):29-34. PubMed ID: 8835001
[TBL] [Abstract][Full Text] [Related]
9. Surgical management of regional lymph nodes in patients with melanoma. Experience with 4682 patients.
Slingluff CL; Stidham KR; Ricci WM; Stanley WE; Seigler HF
Ann Surg; 1994 Feb; 219(2):120-30. PubMed ID: 8129482
[TBL] [Abstract][Full Text] [Related]
10. Sentinel-node biopsy or nodal observation in melanoma.
Morton DL; Thompson JF; Cochran AJ; Mozzillo N; Elashoff R; Essner R; Nieweg OE; Roses DF; Hoekstra HJ; Karakousis CP; Reintgen DS; Coventry BJ; Glass EC; Wang HJ;
N Engl J Med; 2006 Sep; 355(13):1307-17. PubMed ID: 17005948
[TBL] [Abstract][Full Text] [Related]
11. Nodal basin recurrence following lymph node dissection for melanoma: implications for adjuvant radiotherapy.
Lee RJ; Gibbs JF; Proulx GM; Kollmorgen DR; Jia C; Kraybill WG
Int J Radiat Oncol Biol Phys; 2000 Jan; 46(2):467-74. PubMed ID: 10661355
[TBL] [Abstract][Full Text] [Related]
12. Early recurrence after lymphatic mapping and sentinel node biopsy in patients with primary extremity melanoma: a comparison with elective lymph node dissection.
Clary BM; Mann B; Brady MS; Lewis JJ; Coit DG
Ann Surg Oncol; 2001 May; 8(4):328-37. PubMed ID: 11352306
[TBL] [Abstract][Full Text] [Related]
13. Role of elective lymph node dissection in stage I malignant melanoma: evaluation by matched pair analysis.
Rompel R; Garbe C; Büttner P; Teichelmann K; Petres J
Recent Results Cancer Res; 1995; 139():323-36. PubMed ID: 7597301
[TBL] [Abstract][Full Text] [Related]
14. Survival analysis and clinicopathological factors associated with false-negative sentinel lymph node biopsy findings in patients with cutaneous melanoma.
Nowecki ZI; Rutkowski P; Nasierowska-Guttmejer A; Ruka W
Ann Surg Oncol; 2006 Dec; 13(12):1655-63. PubMed ID: 17016755
[TBL] [Abstract][Full Text] [Related]
15. Tumor mitotic rate added to the equation: melanoma prognostic factors changed? : a single-institution database study on the prognostic value of tumor mitotic rate for sentinel lymph node status and survival of cutaneous melanoma patients.
Speijers MJ; Bastiaannet E; Sloot S; Suurmeijer AJ; Hoekstra HJ
Ann Surg Oncol; 2015 Sep; 22(9):2978-87. PubMed ID: 25605514
[TBL] [Abstract][Full Text] [Related]
16. Long-term results of a multi-institutional randomized trial comparing prognostic factors and surgical results for intermediate thickness melanomas (1.0 to 4.0 mm). Intergroup Melanoma Surgical Trial.
Balch CM; Soong S; Ross MI; Urist MM; Karakousis CP; Temple WJ; Mihm MC; Barnhill RL; Jewell WR; Wanebo HJ; Harrison R
Ann Surg Oncol; 2000 Mar; 7(2):87-97. PubMed ID: 10761786
[TBL] [Abstract][Full Text] [Related]
17. Nodal and systemic recurrence following observation of a positive sentinel lymph node in melanoma.
Bartlett EK; Lee AY; Spanheimer PM; Bello DM; Brady MS; Ariyan CE; Coit DG
Br J Surg; 2020 Oct; 107(11):1480-1488. PubMed ID: 32484242
[TBL] [Abstract][Full Text] [Related]
18. Surgical management of patients with intermediate thickness melanoma: current role of elective lymph node dissection.
Cole DJ; Baron PL
Semin Oncol; 1996 Dec; 23(6):719-24. PubMed ID: 8970593
[TBL] [Abstract][Full Text] [Related]
19. Predictors of occult nodal metastasis in patients with thin melanoma.
Faries MB; Wanek LA; Elashoff D; Wright BE; Morton DL
Arch Surg; 2010 Feb; 145(2):137-42. PubMed ID: 20157080
[TBL] [Abstract][Full Text] [Related]
20. Sentinel node biopsy versus elective lymph node dissection in patients with cutaneous melanoma in a Japanese population.
Tsutsumida A; Furukawa H; Yamamoto Y; Horiuchi K; Yoshida T; Minakawa H; Fujii S; Murao N; Kuwahara H; Minamimoto T; Fujioka H; Sakamoto T; Honma T
Int J Clin Oncol; 2007 Aug; 12(4):245-9. PubMed ID: 17701001
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
